Core Viewpoint - The Cigna Group (NYSE:CI) is identified as a strong low volatility large cap stock with a Buy rating and a price target of $378 set by Bank of America Securities analyst Kevin Fischbeck [1][2]. Financial Outlook - The rating is based on the company's solid financial outlook and strategic positioning, particularly regarding its transition to a rebate-free model for its Pharmacy Benefit Manager (PBM) business, which is perceived as misunderstood by the market [2]. - Concerns about potential margin compression are acknowledged, but the new model is seen as providing a competitive advantage [2]. Investment Potential - The Cigna Group's strong free cash flow yield and potential for stock buybacks further support the optimistic outlook, with upcoming strategic disclosures and financial results expected to enhance clarity and catalyze stock performance [3]. - The current trading price indicates significant upside potential, with a median price target of $278.83 suggesting a 23.70% upside from current levels [4]. Business Segments - The Cigna Group operates through several segments, including Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate [4].